Active Stocks
Thu Apr 18 2024 15:59:07
  1. Tata Steel share price
  2. 160.00 -0.03%
  1. Power Grid Corporation Of India share price
  2. 280.20 2.13%
  1. NTPC share price
  2. 351.40 -2.19%
  1. Infosys share price
  2. 1,420.55 0.41%
  1. Wipro share price
  2. 444.30 -0.96%
Business News/ Companies / Lupin, Natco alliance to sell Tykerb
BackBack

Lupin, Natco alliance to sell Tykerb

Staff Writer

Lupin, Natco alliance to sell Tykerb

Premium

Mumbai: Local drug makers Lupin Ltd and Natco Pharma Ltd have jointly stated on Thursday that they will jointly develop and market a generic version of British drug maker Glaxo SmithKline Plc’s patented cancer drug Tykerb.

Glaxo posted sales of $113.6 million for this cancer drug, known as lapatinib ditosylate by chemical name, in March.

Hyderabad-based cancer specialty company Natco had already sought drug regulator’s approval for this generic drug by challenging Glaxo’s patent.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 23 Jun 2011, 10:45 PM IST
Next Story footLogo
Recommended For You

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

Yes, Continue

You are just one step away from creating your watchlist!

Login Now

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.

Your session has expired, please login again.

Yes, Continue
Switch to the Mint app for fast and personalized news - Get App